Get started
Author

Kerstin Wimmer

Observed names: K Wimmer, K. Wimmer, Wimmer Kerstin, Wimmer, Kerstin
ORCID: 0000-0001-5484-6229
Observed ORCID: 0000-0001-5484-6229
OpenAlex ID: A5034508175
Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries
2021 · Stephen R Knight, Catherine A Shaw, et al. · The Lancet · 328
PDF
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
2021 · Michael Gnant, Florian Fitzal, et al. · New England Journal of Medicine · 159
PDF
Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis
2022 · Edvin Ostapenko, Larissa Nixdorf, et al. · Annals of Surgical Oncology · 153
PDF
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study
2024 · Giacomo Montagna, Alison Laws, et al. · Journal of Clinical Oncology · 52
PDF
Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
2019 · K. Wimmer, M. Bolliger, et al. · Annals of Surgical Oncology · 44
PDF
Circulating biomarkers of cell death
2019 · Kerstin Wimmer, Monika Sachet, et al. · Clinica Chimica Acta · 41
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
2022 · Stephen R Knight, Catherine A Shaw, et al. · The Lancet Global Health · 35
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
2023 · Maximilian Marhold, Simon Udovica, et al. · OncoImmunology · 33
Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases
2016 · Kerstin Wimmer, Christoph Schwarz, et al. · Annals of Surgical Oncology · 25
PDF
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study
2025 · Giacomo Montagna, Michael Alvarado, et al. · The Lancet Oncology · 22
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
2023 · Kerstin Wimmer, Monika Sachet, et al. · Journal of Experimental & Clinical Cancer Research · 20
PDF
Long-term outcomes of adjuvant denosumab in breast cancer: Fracture reduction and survival results from 3,425 patients in the randomised, double-blind, placebo-controlled ABCSG-18 trial.
2022 · Michael Gnant, Sophie Frantal, et al. · Journal of Clinical Oncology · 20
Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience
2023 · Felix Harpain, Christopher Dawoud, et al. · Annals of Surgical Oncology · 13
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer
2018 · Stephanie Strobl, Kerstin Wimmer, et al. · Current Treatment Options in Oncology · 13
Optimal duration of adjuvant endocrine therapy: how to apply the newest data
2017 · Kerstin Wimmer, Stephanie Strobl, et al. · Therapeutic Advances in Medical Oncology · 12
PDF
The Impact of Adjuvant Radiotherapy on Immediate Prepectoral Implant-Based Breast Reconstruction
2023 · Edvin Ostapenko, Larissa Nixdorf, et al. · Aesthetic Plastic Surgery · 11
Ptotic versus Nonptotic Breasts in Nipple-sparing Mastectomy and Immediate Prepectoral Breast Reconstruction
2023 · Edvin Ostapenko, Larissa Nixdorf, et al. · Plastic & Reconstructive Surgery Global Open · 10
Short-term outcome after ventral hernia repair using self-gripping mesh in sublay technique – A retrospective cohort analysis
2020 · Felix Harpain, Kerstin Wimmer, et al. · International Journal of Surgery · 9
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
2024 · Kerstin Wimmer, Dominik Hlauschek, et al. · Breast Cancer Research and Treatment · 4
PDF
Differential effects of epirubicin and docetaxel on the immune system in patients with breast cancer (BC).
2020 · Kerstin Wimmer, Monika Sachet, et al. · Journal of Clinical Oncology · 3
Abstract P3-06-10: Immune-related adverse events (irAEs) and pathological complete response (pCR) rates in patients receiving neoadjuvant chemotherapy (CHT) and pembrolizumab (PEM) for early triple-negative breast cancer (eTNBC)
2023 · Maximilian Marhold, Simon Udovica, et al. · Cancer Research · 2
Expert Discussion: ASCO 2022
2022 · Marija Balic, Kerstin Wimmer, et al. · Breast Care · 2
PDF
Current surgical standards in the management of the axilla
2026 · Kerstin Wimmer, Florian Fitzal · memo - Magazine of European Medical Oncology · 1
PDF
Retrospective analysis of real-world elacestrant use in two large Austrian cancer centers
2026 · Lisa Vesenmayer, Simon Udovica, et al. · Breast Care
PDF
Neoadjuvant pembrolizumab-based therapy versus dual HER2 blockade in early breast cancer: comparable surgical complication rates in a real-world cohort
2026 · Kerstin Wimmer, Katharina Kantner, et al. · Frontiers in Medicine
PDF
Works count: 44
Citation count: 1,011
H-index: 13
I10-index: 17
Year
Topic
Type